𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics of intravenous bisoprolol in obese and non-obese volunteers

✍ Scribed by C. Jeunne; J. M. Poirier; G. Cheymol; O. Ertzbischoff; F. Engel; F. C. Hugues


Publisher
Springer
Year
1991
Tongue
English
Weight
419 KB
Volume
41
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

✦ Synopsis


The pharmacokinetics of a single i.v. dose of dl-bisoprolol 0.16 mg.kg-1 ideal body weight has been studied in 8 obese women (mean weight 91 kg; 161% of ideal body weight) and 8 non-obese women (51 kg; 94% of ideal body weight). Compared to the controls, the obese subjects showed an increase in the total apparent volume of distribution (Vz) (182 vs 1351) and a decrease in Vz per kg body weight (2 vs 2.71.kg-1). There was a negative correlation between Vz l.kg-1 and the percentage of ideal body weight (r = -0.672). Total body clearance was increased, but t1/2 and renal clearance was unchanged. It is concluded that tissue diffusion of bisoprolol in obese subjects is limited, despite its lipophilicity, possibly because of alteration in the blood flow to adipose tissue produced by bisoprolol.


πŸ“œ SIMILAR VOLUMES


Different aetiologies of Type 2 (non-ins
✍ P. Arner; T. Pollare; H. Lithell πŸ“‚ Article πŸ“… 1991 πŸ› Springer 🌐 English βš– 506 KB

Insulin responses to intravenous glucose infusion and glucose utilization during hyperinsulinaemic euglycaemic clamp were determined in a large homogeneous group of 65-year-old male subjects. Twenty-eight had untreated Type 2 (non-insulin-dependent) diabetes mellitus and the remaining 44 control sub

Thought suppression in obese and non-obe
✍ Barbara Soetens; Caroline Braet; Ellen Moens πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 133 KB

## Abstract ## Objective This article examines thought suppression tendencies in restrained eaters. Furthermore, the dynamics between failing thought suppression and thought control strategies are explored. ## Methods One hundred and five overweight and normal‐weight boys and girls (12–18 years)